QBECO SSI
AssetAlso QBECO
Inactivated E. coli components restore innate immune homeostasis in the gastrointestinal tract and related organs.
- Stage
- Phase 2
- Modality
- Other
- Target
- Not known
- 4
- Indications
- 0
- Trials
- 1
- Developer
Indications
4Colon cancer
Phase 2, qubiologics.com, 10 Oct 2026
Crohn's disease
Phase 2, qubiologics.com, 10 Oct 2026
Ovarian cancer
Phase 2, qubiologics.com, 10 Oct 2026
1 more
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.